Frank E Thomas - Net Worth and Insider Trading
Frank E Thomas Net Worth
The estimated net worth of Frank E Thomas is at least $2 Million dollars as of 2024-03-28. Frank E Thomas is the President & COO of AMAG Pharmaceuticals Inc and owns about 109,309 shares of AMAG Pharmaceuticals Inc (AMAG) stock worth over $2 Million. Frank E Thomas is also the Director of Larimar Therapeutics Inc and owns about 2,000 shares of Larimar Therapeutics Inc (LRMR) stock worth over $14,520. Details can be seen in Frank E Thomas's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Frank E Thomas has not made any transactions after 2024-02-14 and currently still holds the listed stock(s).
Transaction Summary of Frank E Thomas
Frank E Thomas Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Frank E Thomas owns 4 companies in total, including Larimar Therapeutics Inc () , Orchard Therapeutics PLC () , and Spero Therapeutics Inc () among others .
Click here to see the complete history of Frank E Thomas’s form 4 insider trades.
Insider Ownership Summary of Frank E Thomas
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
Larimar Therapeutics Inc | 2024-02-14 | director | |
Orchard Therapeutics PLC | 2020-01-01 | See Remarks | |
Spero Therapeutics Inc | 2017-11-01 | director | |
AMAG Pharmaceuticals Inc | 2017-02-23 | President & COO |
Frank E Thomas Latest Holdings Summary
Frank E Thomas currently owns a total of 2 stocks. Among these stocks, Frank E Thomas owns 109,309 shares of AMAG Pharmaceuticals Inc (AMAG) as of August 5, 2015, with a value of $2 Million and a weighting of 99.04%. Frank E Thomas also owns 2,000 shares of Larimar Therapeutics Inc (LRMR) as of February 14, 2024, with a value of $14,520 and a weighting of 0.96%.
Latest Holdings of Frank E Thomas
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AMAG | AMAG Pharmaceuticals Inc | 2015-08-05 | 109,309 | 13.75 | 1,502,999 |
LRMR | Larimar Therapeutics Inc | 2024-02-14 | 2,000 | 7.26 | 14,520 |
Holding Weightings of Frank E Thomas
Frank E Thomas Form 4 Trading Tracker
According to the SEC Form 4 filings, Frank E Thomas has made a total of 0 transactions in AMAG Pharmaceuticals Inc (AMAG) over the past 5 years. The most-recent trade in AMAG Pharmaceuticals Inc is the sale of 15,000 shares on August 5, 2015, which brought Frank E Thomas around $1 Million.
According to the SEC Form 4 filings, Frank E Thomas has made a total of 1 transactions in Larimar Therapeutics Inc (LRMR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Larimar Therapeutics Inc is the acquisition of 2,000 shares on February 14, 2024, which cost Frank E Thomas around $22,000.
Insider Trading History of Frank E Thomas
- 1
Frank E Thomas Trading Performance
GuruFocus tracks the stock performance after each of Frank E Thomas's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Frank E Thomas is -8.98%. GuruFocus also compares Frank E Thomas's trading performance to market benchmark return within the same time period. The performance of stocks bought by Frank E Thomas within 3 months outperforms 1 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Frank E Thomas's insider trading performs compared to the benchmark.
Performance of Frank E Thomas
Average Relative Return
10.09%
Outperforming Transactions
50%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Relative Return(%) | -7.45 | -8.98 | -3.68 | 10.09 | 13.11 | 42.05 |
Relative Return to S&P 500(%) | -10.13 | -10.5 | -7.61 | -2.32 | -3.77 | 26.91 |
Frank E Thomas Ownership Network
Ownership Network List of Frank E Thomas
Ownership Network Relation of Frank E Thomas
Frank E Thomas Owned Company Details
What does Larimar Therapeutics Inc do?
Who are the key executives at Larimar Therapeutics Inc?
Frank E Thomas is the director of Larimar Therapeutics Inc. Other key executives at Larimar Therapeutics Inc include 10 percent owner & other: Possible Member of 10% Group James E Flynn , Chief Development Officer Gopi Shankar , and Chief Medical Officer Russell Clayton .
Larimar Therapeutics Inc () Insider Trades Summary
Over the past 18 months, Frank E Thomas made 1 insider transaction in Larimar Therapeutics Inc () with a net purchase of 2,000. Other recent insider transactions involving Larimar Therapeutics Inc () include a net purchase of 4,290,617 shares made by James E Flynn , a net purchase of 5,000 shares made by Carole Ben-maimon , and a net purchase of 5,000 shares made by Gopi Shankar .
In summary, during the past 3 months, insiders sold 0 shares of Larimar Therapeutics Inc () in total and bought 4,292,617 shares, with a net purchase of 4,292,617 shares. During the past 18 months, 0 shares of Larimar Therapeutics Inc () were sold and 4,310,367 shares were bought by its insiders, resulting in a net purchase of 4,310,367 shares.
Larimar Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.
Larimar Therapeutics Inc Insider Transactions
Frank E Thomas Mailing Address
Above is the net worth, insider trading, and ownership report for Frank E Thomas. You might contact Frank E Thomas via mailing address: C/o Orchard Therapeutics, 101 Seaport Boulevard, 7th Floor, Boston Ma 02210.